GW Pharmaceuticals PLC (GWPH) Q1 2020 earnings call dated May. 11, 2020 Corporate Participants: Stephen Schultz -- Vice President, Investor Relations Justin Gover -- Chief Executive
The cannabis market, which has been witnessing issues like low demand and the vaping crisis, is probably headed for a slowdown this
Cronos Group Inc. (CRON) Q1 2020 earnings call dated May 08, 2020 Corporate Participants: Shayne Laidlaw -- Investor Relations Mike Gorenstein -- Chairman, President and Chief
Cronos Group Inc. (NASDAQ: CRON) reported a 76% dip in earnings for the first quarter of 2020 due to higher operating expenses
Aphria Inc (APHA) Q3 2020 earnings call dated Apr. 15, 2020 Corporate Participants: Katie M. Turner -- Investor Relations Irwin D. Simon -- Chief Executive Officer Carl
Village Farms International Inc. (NASDAQ: VFF) Q4 2019 Earnings Conference Call Mar. 31, 2020 Corporate Participants: Michael A. DeGiglio -- President & Chief Executive Officer
Aphria Inc (NYSE: APHA) Q2 2020 Earnings Conference Call January 14, 2020 Corporate Participants: Katie M. Turner -- Managing Director Irwin D. Simon -- Interim Chief Executive
HEXO Corp. (NYSE: HEXO) Q2 2020 Earnings Conference Call Mar. 30, 2020 Corporate Participants: Jennifer Smith -- Director, Investor Relations Sebastien St-Louis -- Co-Founder and Chief Executive
Cronos Group Inc. (NASDAQ: CRON) Q4 2019 Earnings Conference Call Mar. 30, 2020 Corporate Participants: Anna Shlimak -- Investor Relations Mike Gorenstein -- Chairman, President and Chief
Cronos Group Inc. (NASDAQ: CRON) swung to a profit in the fourth quarter of 2019 from a loss last year, helped by
HEXO Corp.'s (TSX: HEXO; NYSE: HEXO) loss expanded in the second quarter of 2020, hurt by significant impairment charges. Hexo posted a
Arcadia Biosciences' (NASDAQ: RKDA) loss expanded, while revenue dropped in the fourth quarter of 2019. The agricultural food ingredient company posted a
Aurora Cannabis Inc (NYSE: ACB) Q2 2020 Earnings Conference Call February 13, 2020 Corporate Participants: Michael Singer -- Interim Chief Executive Officer and Executive
For GW Pharmaceuticals (NASDAQ: GWPH), the main growth strategy for the current fiscal year is to expand its product pipeline beyond Epidiolex,
Days after announcing an extensive restructuring program, which includes tough measures like workforce reduction, cannabis producer Tilray, Inc. (NASDAQ: TLRY) reported a
Tilray (Nasdaq: TLRY) will issue its fourth quarter and full-year 2019 earnings results on Monday, March 2, 2020 after the market close.
GW Pharmaceuticals plc (NASDAQ: GWPH) is slated to report fourth quarter 2019 earnings results on Tuesday, February 25, after the market closes.
Though there are clear indications that the cannabis bubble is about to burst, the performance of certain pot stocks shows that not
Presenting the first quarterly report under its new CEO, Canopy Growth Corporation (NYSE: CGC) posted a net loss for the third quarter
Canadian-based major pot producer Canopy Growth (NYSE: CGC) (TSX: WEED) is poised to publish its third quarter 2020 earnings results tomorrow early morning.
For Aurora Cannabis, Inc. (NYSE: ACB), the last few months have been momentous, marked by key organizational changes including an executive reshuffle.